WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The safety and efficacy of WAL 801 CL (epinastine hydrochloride) Dry Syrup in the treatment
of atopic dermatitis in children was evaluated and plasma drug concentrations were measured.